These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 30643381

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Loteprednol etabonate ophthalmic gel 0.5% following cataract surgery: integrated analysis of two clinical studies.
    Rajpal RK, Fong R, Comstock TL.
    Adv Ther; 2013 Oct; 30(10):907-23. PubMed ID: 24136301
    [Abstract] [Full Text] [Related]

  • 5. Safety of KPI-121 Ophthalmic Suspension 0.25% in Patients With Dry Eye Disease: A Pooled Analysis of 4 Multicenter, Randomized, Vehicle-Controlled Studies.
    Korenfeld M, Nichols KK, Goldberg D, Evans D, Sall K, Foulks G, Coultas S, Brazzell K.
    Cornea; 2021 May 01; 40(5):564-570. PubMed ID: 32826644
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Submicron loteprednol etabonate ophthalmic gel 0.38% for the treatment of inflammation and pain after cataract surgery.
    Fong R, Silverstein BE, Peace JH, Williams JI, Vittitow JL.
    J Cataract Refract Surg; 2018 Oct 01; 44(10):1220-1229. PubMed ID: 30193927
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. KPI-121 1% for pain and inflammation in ocular surgery.
    Beckman KA, Katz JA, Majmudar PA, Rips AG, Vaidya NS, Rostov AT.
    Pain Manag; 2022 Jan 01; 12(1):17-23. PubMed ID: 34164994
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and tolerability of besifloxacin ophthalmic suspension 0.6% administered twice daily for 3 days in the treatment of bacterial conjunctivitis: a multicenter, randomized, double-masked, vehicle-controlled, parallel-group study in adults and children.
    Silverstein BE, Allaire C, Bateman KM, Gearinger LS, Morris TW, Comstock TL.
    Clin Ther; 2011 Jan 01; 33(1):13-26. PubMed ID: 21397770
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Bromfenac ophthalmic solution 0.07% dosed once daily for cataract surgery: results of 2 randomized controlled trials.
    Walters TR, Goldberg DF, Peace JH, Gow JA, Bromfenac Ophthalmic Solution 0.07% Once Daily Study Group.
    Ophthalmology; 2014 Jan 01; 121(1):25-33. PubMed ID: 24021896
    [Abstract] [Full Text] [Related]

  • 14. A randomized double-masked study to compare the ocular safety, tolerability, and efficacy of bromfenac 0.075% compared with vehicle in cataract surgery subjects.
    Hosseini K, Walters T, DaVanzo R, Lindstrom RL.
    Clin Ophthalmol; 2016 Jan 01; 10():2311-2317. PubMed ID: 27920490
    [Abstract] [Full Text] [Related]

  • 15. Nepafenac dosing frequency for ocular pain and inflammation associated with cataract surgery.
    Maxwell WA, Reiser HJ, Stewart RH, Cavanagh HD, Walters TR, Sager DP, Meuse PA.
    J Ocul Pharmacol Ther; 2008 Dec 01; 24(6):593-9. PubMed ID: 19040348
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A double-masked, placebo-controlled evaluation of 0.5% loteprednol etabonate in the treatment of postoperative inflammation. The Loteprednol Etabonate Postoperative Inflammation Study Group 2.
    Ophthalmology; 1998 Sep 01; 105(9):1780-6. PubMed ID: 9754192
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. OCS-01 (Novel Topical Dexamethasone Formulation) in Inflammation and Pain Post Cataract Surgery: A Randomized, Double-Masked, Vehicle-Controlled Study.
    Korenfeld M, Gira J, Jong K, Martel J, Vold S, Walters T, Usner D, Donnenfeld E.
    Clin Ther; 2022 Dec 01; 44(12):1577-1587. PubMed ID: 36503736
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.